NSE filing, NSE: FAZE3Q. Summary written from the filing by ALFA Finder's alert engine.
Faze Three Ltd: key numbers
- Share price
- ₹413.15
- Market cap
- ₹1,016 Cr
- Revenue (annual)
- ₹923.1 Cr
- Net profit (annual)
- ₹33.57 Cr
- P/E (TTM)
- 33.4×Sector 49.0×
- Promoter holding
- 57.35%-0.66% QoQ
- FII holding
- 0.14%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Faze Three Ltd
All →Faze Three Other Announcement
Faze Three Ltd submitted its quarterly shareholding pattern for the period ended September 30, 2026, including an explanatory note regarding ESOP Trust shareholding adjustments.
Faze Three Business Update
Faze Three Limited informed the exchange about an interview of its President, Vishnu Anand, published in Dun & Bradstreet's 'Business Enterprises of Tomorrow' report.
Faze Three Management Change
Faze Three Limited has appointed Mr. Mohit Dinesh Solanki as an Independent Director for a five-year term effective August 17, 2026. The appointment was approved at the AGM.
Faze Three Annual General Meeting
Faze Three Limited concluded its 41st Annual General Meeting on September 4, 2026. Shareholders transacted ordinary and special business resolutions.
Faze Three Other Announcement
Faze Three Limited has submitted the First Supplemental Trust Deed of its Employee Trust to the stock exchanges. This amendment records changes in the appointed trustees.
Faze Three Annual Report
Faze Three Limited submitted its 41st Annual Report for FY 2025-26 and the Notice convening the 41st Annual General Meeting scheduled for September 04, 2026.
Other employee stock options announcements
All →Aye Finance Employee Stock Options
Aye Finance's employee welfare trust transferred 89,501 equity shares to grantees on exercising ESOP options. The share capital remains unchanged, so no new issuance occurs.
Aarti Pharmalabs Employee Stock Options
Aarti Pharmalabs granted 850 stock options to employees under its PSOP 2023 at Rs.5 exercise price. This is an employee incentive grant, not a capital raise.
OnEMI Technology Solutions Employee Stock Options
OnEMI Technology allotted 69,000 equity shares on exercise of employee stock options under the Kissht ESOP 2022 plan. The shares rank pari passu with existing equity.
Bliss GVS Pharma Employee Stock Options
Bliss GVS Pharma seeks shareholder approval via postal ballot for new employee stock option plans 2026. Up to 26,50,000 options are proposed; voting closes November 27, 2026.
Bandhan Bank Employee Stock Options
Bandhan Bank's board granted 32,98,871 stock options under ESOP Series 1 (Tranche 9) at Rs 151.91 per option. The options vest over four years, with each option convertible into one equity share.
Maxvolt Energy Industries Employee Stock Options
Maxvolt Energy granted 5,01,726 ESOPs to six employees under its MEIL ESOP 2025 scheme at exercise prices of ₹30 and ₹45. Options vest over four years, with exercise windows following vesting.
- Execution
- Vesting over 4 years from grant (25% at 2nd, 25% at 3rd, 50% at 4th anniversary); exercise over 3 years from each vesting date